| Page 2093 | Kisaco Research
 

Sushil Nanda

VP for Process Excellence and Automation
State Street

Sushil Nanda is VP for Process Excellence and Automation through Robotics and Lean (PEARL) program at State Street. Driving several diversified global enterprise-wide RPA initiatives from ideation to business case formation until delivering RPA solution for benefit realization.

Sushil Nanda

VP for Process Excellence and Automation
State Street

Sushil Nanda

VP for Process Excellence and Automation
State Street

Sushil Nanda is VP for Process Excellence and Automation through Robotics and Lean (PEARL) program at State Street. Driving several diversified global enterprise-wide RPA initiatives from ideation to business case formation until delivering RPA solution for benefit realization.

Pankajam Sridevi on the ANZ RPA journey
Video: Beauty and Money Summit LA Highlights
 
CAR-T Congress USA
20-22 Mar 2018
Boston, USA
The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in depth view into this expansive area.
 

Dr Noushin Dianat

CEO
Cyprio

Being a liver bioengineering enthusiast, in 2014, Noushin joined Laboratory of Colloids and Divided Materials (LCMD) at ESPCI Paris (The City of Paris Industrial Physics and Chemistry Higher Educational Institution) as a postdoctoral fellow and developed a novel 3D liver model adapted for high throughput drug screening through a collaborative project with Sanofi.

Dr Noushin Dianat

CEO
Cyprio

Dr Noushin Dianat

CEO
Cyprio

Being a liver bioengineering enthusiast, in 2014, Noushin joined Laboratory of Colloids and Divided Materials (LCMD) at ESPCI Paris (The City of Paris Industrial Physics and Chemistry Higher Educational Institution) as a postdoctoral fellow and developed a novel 3D liver model adapted for high throughput drug screening through a collaborative project with Sanofi.